PLRX
Pliant Therapeutics Inc
1.00$
-1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 24.8% | 104.4% | 56.0% | 18.0% | 69.5% | 53.6% | 79.7% | 445.2% | – | 9.6% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 46.4% | 20.3% | -345.2% | – | 90.4% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | – | – | – | 20.6% | 48.1% | 487.1% | 350.7% | 399.9% | 852.2% | 1,074.2% | 1,307.6% | 938.1% | 1,671.8% | 527.9% | 1,660.3% | 1,224.5% | 2,118.0% | 12,862.1% | – | 685.6% | – | – | – | 1,708.9% | – | – | – | – | – | – | – | |
| – | – | – | – | 5.4% | 13.9% | 84.4% | 95.4% | 126.0% | 302.0% | 306.0% | 476.5% | 392.5% | 686.9% | 166.3% | 595.3% | 725.2% | 1,062.6% | 5,876.6% | – | 286.2% | – | – | – | 640.0% | – | – | – | – | – | – | – | |
| – | – | – | – | 26.0% | 62.0% | 571.6% | 446.1% | 525.9% | 1,154.2% | 1,380.3% | 1,784.0% | 1,330.6% | 2,358.7% | 694.1% | 2,255.7% | 1,949.7% | 3,180.6% | 18,738.7% | – | 971.8% | – | – | – | 2,348.9% | – | – | – | – | – | – | – | |
| – | – | – | – | 74.0% | 38.0% | -471.6% | -346.1% | -425.9% | -1,054.2% | -1,280.3% | -1,684.0% | -1,230.6% | -2,258.7% | -594.1% | -2,155.7% | -1,903.3% | -3,160.3% | -19,083.9% | – | -971.8% | – | – | – | -2,348.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 2.9% | 4.1% | 4.2% | 13.6% | 8.9% | 3.5% | 20.3% | 16.1% | 23.3% | 128.6% | – | 6.6% | – | – | – | 36.7% | – | – | – | – | – | – | – | |
| – | – | – | – | 73.9% | 38.1% | -472.3% | -343.5% | -426.1% | -1,051.3% | -1,276.2% | -1,679.8% | -1,227.2% | -2,249.8% | -592.2% | -2,065.8% | -1,784.2% | -2,818.9% | -16,609.7% | – | -849.4% | – | – | – | -2,190.8% | – | – | – | – | – | – | – | |
| – | – | – | – | -0.2% | -0.7% | -3.1% | -8.4% | -9.7% | – | -1.7% | -0.7% | 13.6% | -17.8% | 5.4% | -179.8% | -23.2% | -706.1% | 2,602.8% | – | 70.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 70.2% | 38.1% | -472.3% | -343.5% | -426.1% | -1,051.3% | -1,276.2% | -1,679.8% | -1,227.2% | -2,249.8% | -592.2% | -2,065.8% | -1,784.2% | -2,818.9% | -16,609.7% | – | -849.4% | – | – | – | -2,190.8% | – | – | – | – | – | – | – | |
| – | – | – | – | 74.5% | 39.1% | -462.6% | -339.2% | -418.1% | -1,037.7% | -1,255.5% | -1,655.7% | -1,206.3% | -2,213.4% | -579.6% | -2,014.8% | -1,715.8% | -2,715.9% | -16,035.9% | – | -833.1% | – | – | – | -2,133.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.